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The start of a new year always brings a certain amount of change and MSJ is no different. The annual 
editorial comment always looks back across the previous volumes, reporting on highlights but also, 
this year, reflecting on forthcoming changes to the Editorial Team.  
After 12 years Jack Antel has decided to step down from the journal and in January 2019 we are 
welcoming Jeff Cohen as Co-Editor for the Americas. Jeff is joining MSJ from MSJ-ETC where he was 
a founding Editor for the journal handling papers from the Americas. Jeff is also the President-Elect 
for ACTRIMS 2016-2019, where he will again succeed Jack. Jack has been co-Editor for the Americas 
since 2006 and as four global editors we have worked together to shape the journal into what it is 
today, the most established MS journal with an Impact Factor over 5.  
In 2006 I wrote my first editorial 
http://journals.sagepub.com/doi/pdf/10.1191/135248506ms1285ed) and discussed how Jack’s 
energy and enthusiasm would help drive the journal forward. It was my hope that Jack would most 
importantly promote translational research both in the form of basic research studies that can guide 
clinical development and studies that apply basic research methods to relevant clinical material. 
Over the last 12 years Jack has handled papers from America with that same enthusiasm and 
unwavering dedication. Within the last year he put together the MSJ basic science collection to 
continue pushing the journal towards basic science research that is directly relevant to MS. On 
behalf of SAGE, reviewers, the other editors and all the authors attended to by Jack, we would like 
sincerely thank him for all his work.  
In addition to Jack’s stepping down there will be considerable movement within the team of Editors 
working on MSJ and MSJ-ETC. We have put together a dedicated page detailing who is who to 
ensure you, our readers, are kept up to date 
http://journals.sagepub.com/msj/multiplesclerosisjournaleditorialteam.  For 2019 MSJ thanks Ruth 
Ann Marrie for all her work on the Controversies as she is moving MSJ-ETC to become Editor for the 
Americas succeeding Jeff. As a result we welcome Jaume Sastre-Garriga as Co-Editor for the 
Controversies replacing Ruth Ann Marrie. Collectively the Editors are keen to ensure there is 
diversity and inclusion within the Editorial Board to reflect those working in the field of MS. Concern 
has recently been voiced that women are underrepresented in leadership roles in MS research and 
clinical trials. Currently 31% of the MSJ Editorial Board are women and we will continue to develop a 
board that reflects the range of subject expertise in the MS field, has equal gender participation and 
is geographically and ethnically diverse.  
In 2018 MSJ published the ECTRIMS/EAN guideline on the pharmacological treatment of people with 
multiple sclerosis and an Editorial entitled 2017 McDonald MS diagnostic criteria: Evidence-based 
revisions by Co-Editor William (Bill) Carroll. Both papers have helped to move the field forward and 
provide clear insights to all our readers.  
The themed issue on Environmental factors, genetics and epigenetics in MS susceptibility and clinical 
course put together from the ACTRIMS Forum 2017 was a highlight for 2018. Jeff Cohen and Ben 
Segal guest edited the issue and it was made open access thanks to ACTRIMS generosity which has 
helped to increase its availability. 
In 2018 the journal was also fortunate to benefit from publishing two sets of ‘Insights into’. Philip De 
Jager put together an enlightening series on the complex area of Epigenetics (insert collection link) 
and Sergio Baranzini is currently publishing a series on Microbiome Research 
(http://journals.sagepub.com/topic/collections-msj/msj-1-microbiome_research/msj).  
The journal continues to benefit from fascinating original contributions, which are at the heart of the 
journal. We are always grateful to the willingness of our reviewers and editorial board members to 
put in the time and effort to make sure that the best possible papers are published in MSJ. Over the 
last year we have been increasingly rigorous with our decisions to ensure MSJ is publishing the very 
best. As Editors we recognise the frustration and disappointment when papers are rejected and we 
welcome feedback on how to improve the process; a topic frequently discussed at the Editorial 
Board meeting. Finally we wish to acknowledge the special relationship existing between the journal 
and the “TRIMS” organisations and to congratulate the awardees of the MSJ prizes given at their 
meetings this year. 
Together with the MSJ staff at Sage Publishing we wish everyone a joyful and safe end of year break 
and continuing success for the journal to mirror our further understanding of multiple sclerosis and 
the development of improved treatments for people with multiple sclerosis. 
 
